Publications by authors named "Rossana Palumbo"
Transl Med UniSa
August 2024
Article Synopsis
- Despite improvements in treatment strategies for post-acute coronary syndrome (ACS) patients, there remains a high occurrence of recurrent ischemic events, highlighting the need for new therapeutic targets to reduce cardiovascular risk.
- Chronic inflammation, specifically the role of inflammasomes, has been linked to the development of atherosclerosis, leading to interest in drugs like colchicine and monoclonal antibodies that may enhance cardiovascular outcomes.
- Additionally, lipoprotein(a) and gut microbiome alterations are emerging as significant risk factors, with potential therapies for lowering Lp(a) showing promise, while targeted microbiome studies still require further research.
